CIK: 1373110 - Address: C/O Poseida Therapeutics, Inc., 9390 Towne Center Drive Suite 200, San Diego, CA 92121
34 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret2118-0-0-0-2-16-39-10
S%wins67675050699466

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

1/19/16 15:02
1/15/16
MRTXMirati Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsGergen Mark JCAOEVP,COOM.d1288.506156D1821-22-25-28-20-11-3-9-2-12-8-79-79
1/19/16 15:02
1/15/16
MRTXMirati Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsGergen Mark JCAOEVP,COOS.d-25925.926-10-646D1821-22-25-28-20-11-3-9-2-12-8-79-79
3/2/12 19:45
3/1/12
AMLNAmylin Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGergen Mark JCAOHSVP,CorpS-3217.1133-2-363D-131553684810-4-3-8
2/24/12 17:02
2/23/12
AMLNAmylin Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGergen Mark JCAOSVP,CorpS-12817.0333-8-1164D418827560121-1-4
11/2/07 15:18
11/1/07
AMLNAmylin Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGergen Mark JCAOSVP,CorpM.d816.80331213D30-14-9-12-9-7-7-1-8-15-26-35-77
11/2/07 15:18
11/1/07
AMLNAmylin Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGergen Mark JCAOSVP,CorpS.d-2244.0033-1-153D30-14-9-12-9-7-7-1-8-15-26-35-77
10/4/07 18:38
10/3/07
AMLNAmylin Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGergen Mark JCAOSVP,CorpM.d816.80331213D4418311814202-4-13-26-35-62
10/4/07 18:38
10/3/07
AMLNAmylin Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGergen Mark JCAOSVP,CorpS.d-2550.0033-1-153D4418311814202-4-13-26-35-62
10/2/07 14:42
10/1/07
AMLNAmylin Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGergen Mark JCAOSVP,CorpM.d816.80331213D47113319123-1-1-3-6-25-37-59
10/2/07 14:42
10/1/07
AMLNAmylin Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGergen Mark JCAOSVP,CorpS.d-2549.8333-1-153D47113319123-1-1-3-6-25-37-59
9/6/07 16:37
9/4/07
AMLNAmylin Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGergen Mark JCAOSVP,CorpM.d1716.80331523D55735185102-103-24-48-54
9/6/07 16:37
9/4/07
AMLNAmylin Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGergen Mark JCAOSVP,CorpS.d-5049.5033-1-253D55735185102-103-24-48-54
8/8/07 18:32
8/7/07
AMLNAmylin Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGergen Mark JCAOSVP,CorpM.d816.80331213D153625222617870-6-5-20-41-40
8/8/07 18:32
8/7/07
AMLNAmylin Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGergen Mark JCAOSVP,CorpS.d-2550.0033-1-153D153625222617870-6-5-20-41-40
8/2/07 17:05
8/1/07
AMLNAmylin Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGergen Mark JCAOSVP,CorpM.d816.80331213D150-4201113680183-1-38-34
8/2/07 17:05
8/1/07
AMLNAmylin Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGergen Mark JCAOSVP,CorpS.d-2346.5033-1-153D150-4201113680183-1-38-34
7/25/07 10:56
7/24/07
AMLNAmylin Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGergen Mark JCAOSVP,CorpM.d816.80331213D105-2158107235411-2-23-35
7/25/07 10:56
7/24/07
AMLNAmylin Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGergen Mark JCAOSVP,CorpS.d-2345.0033-1-153D105-2158107235411-2-23-35
7/3/07 14:51
7/2/07
AMLNAmylin Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGergen Mark JCAOSVP,CorpM.d816.80331213D96-121612-8202001219-11-37
7/3/07 14:51
7/2/07
AMLNAmylin Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGergen Mark JCAOSVP,CorpS.d-2141.2033-1-153D96-121612-8202001219-11-37
6/4/07 18:11
6/1/07
AMLNAmylin Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGergen Mark JCAOSVP,CorpM.d1716.80331523D19331328131234-1-5-412-14-26
6/4/07 18:11
6/1/07
AMLNAmylin Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGergen Mark JCAOSVP,CorpS.d-4646.1633-1-253D19331328131234-1-5-412-14-26
5/23/07 11:01
5/21/07
AMLNAmylin Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGergen Mark JCAOSVP,CorpM.d816.80331213D1671121119897-11-810-15-32
5/23/07 11:01
5/21/07
AMLNAmylin Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGergen Mark JCAOSVP,CorpS.d-2345.0033-1-153D1671121119897-11-810-15-32
5/2/07 12:14
5/1/07
AMLNAmylin Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGergen Mark JCAOSVP,CorpM.d816.80331213D129-5-871191-210111212-34
5/2/07 12:14
5/1/07
AMLNAmylin Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGergen Mark JCAOSVP,CorpS.d-2141.2533-1-153D129-5-871191-210111212-34
4/3/07 13:37
4/2/07
AMLNAmylin Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGergen Mark JCAOSVP,CorpM.d816.80331213D113-23-173-9-20026131233-16
4/3/07 13:37
4/2/07
AMLNAmylin Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGergen Mark JCAOSVP,CorpS.d-1937.4733-1-153D113-23-173-9-20026131233-16
3/2/07 17:21
3/1/07
AMLNAmylin Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGergen Mark JCAOSVP,CorpM.d816.80331213D74-14-19-9-8-10-8-91-132632-27
3/2/07 17:21
3/1/07
AMLNAmylin Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGergen Mark JCAOSVP,CorpS.d-1937.7533-1-153D74-14-19-9-8-10-8-91-132632-27
2/2/07 11:26
2/1/07
AMLNAmylin Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGergen Mark JCAOSVP,CorpM.d816.80331243D72-9-20-122-3-2008-4923-17
2/2/07 11:26
2/1/07
AMLNAmylin Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGergen Mark JCAOSVP,CorpS.d-1938.7533-1-163D72-9-20-122-3-2008-4923-17
1/4/07 11:17
1/3/07
AMLNAmylin Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGergen Mark JCAOSVP,CorpM.d816.80331302D55-9-26-15-16-6-4-20965171
1/4/07 11:17
1/3/07
AMLNAmylin Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsGergen Mark JCAOSVP,CorpS.d-1836.2933-1-192D55-9-26-15-16-6-4-20965171

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact